OPDYTA 100MG (Nivolumab (100mg))

OPDYTA 100MG INJ contains the active ingredient nivolumab, which is used in the management of certain types of cancer. It works by helping the immune system recognize and attack cancer cells more effectively. This approach aims to support patients in their fight against cancer by potentially improving the body’s natural defense mechanisms.

Nivolumab is categorized as an immune checkpoint inhibitor. It assists the immune system in overcoming the barriers that cancer cells create to evade detection. By blocking specific proteins that prevent immune cells from attacking tumors, nivolumab can enhance the body’s ability to identify and destroy cancerous cells.

For best results, OPDYTA should be stored as directed on the package, typically in a cool, dry place away from direct sunlight. Consistency in treatment is important, and patients are encouraged to follow their healthcare provider’s instructions closely. It’s essential for patients to communicate with their healthcare team about any other medications they are taking and to inform them of any existing health conditions.

Some common side effects that may occur include fatigue, skin rash, and mild gastrointestinal discomfort. These side effects are usually manageable but should be discussed with a healthcare provider if they persist or worsen.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.